Could a One-Time injection of your own immune cells protect your kidneys?
NCT ID NCT06866158
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial is testing whether a single injection of a person's own immune cells (dendritic cells and lymphocytes) can reduce kidney damage in type 2 diabetes. The cells are processed in a lab and then given back under the skin. Researchers will measure urine protein levels and kidney function over four weeks in 80 adults. The goal is to see if this approach can calm inflammation and protect the kidneys.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- autologous dendritic cells and lymphocytes matured with SARS-CoV-2 S protein
- What this could lead to
- If it works, this could point toward a new way to slow or reverse kidney damage in people with type 2 diabetes, potentially reducing the need for dialysis or transplant.
- What could go wrong
- This is a very early (Phase 1/2), small, single-arm trial with no placebo group, so results may be due to chance or natural variation. The treatment uses a coronavirus protein to mature the cells, which is unusual and its safety and effectiveness are unproven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC KIDNEY DISEASE (DKD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gatot Soebroto Central Army Hospital
Jakarta Pusat, DKI Jakarta - Jakarta, 10410, Indonesia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a strong support network help people with diabetic kidney disease take better care of themselves?
- New strategy aims to protect kidneys and hearts in diabetes patients
- New registry aims to uncover real-world diabetic kidney disease care in underserved groups
- New drug aims to shield kidneys and heart in diabetic patients
- New drug combo aims to protect kidneys in diabetes
- Can MRI scans reveal how diabetes drugs shield kidneys?